SCHEMBL24535963

SCHEMBL24535963

C=C(C)NC1CN(CC)CC1CO

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GBA1 P04062 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19122476 0.78 GBA1 (0.38) GBA1
SCHEMBL22920432 0.74 GBA1 (0.35) GBA1
SCHEMBL22920502 0.74 GBA1 (0.35) GBA1
SCHEMBL21424190 0.74 GBA1 (0.35) GBA1
SCHEMBL23054500 0.74 GBA1 (0.35) GBA1
SCHEMBL21424123 0.74 GBA1 (0.35) GBA1
SCHEMBL19087105 0.67 GBA1 (0.41) GBA1
SCHEMBL15295922 0.67 GBA1 (0.55) GBA1
SCHEMBL19123088 0.67 GBA1 (0.55) GBA1
SCHEMBL19098322 0.66 GBA1 (0.40) GBA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022133034-A1 METHODS OF TREATING DISORDERS ASSOCIATED WITH CASTOR ST. JUDE CHILDREN'S RESEARCH HOSPITAL, INC. (US) 2022-06-23 — — WO disclosed
Send feedback